VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb. 23, 2006--Forbes Medi-Tech Inc. (NASDAQ:FMTI) (TSX:FMI) today announced it has agreed to sell its interest in Phyto-Source LP, the Company’s 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., the Japanese parent company of the Company’s joint venture partner, Chusei (U.S.A.) Inc. Simultaneously, Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(TM) and other wood sterols for a period of 5 years. Forbes has agreed to buy all of its sterol requirements exclusively from Phyto-Source for the first year.
